乌比基特异蛋白酶1通过稳定c-MYC促进膀癌的进展
Xia Zhang1, Peng Peng1, Li-Wei Bao1
1Department of Laboratory Medicine, School of Medicine, Hunan Normal University, Changsha 410013, China.
Cells
|November 8, 2024
概括
高基因特异蛋白酶1 (USP1) 的高表达通过稳定c-MYC促进了膀癌的进展. USP1可能是膀癌治疗的新治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 乌比基化是细胞平衡的一个关键的转录后修饰.
- 乌比基因特异蛋白酶1 (USP1),一种二氧化酶,与瘤进展有关.
- 在膀癌中USP1的作用仍然在很大程度上未被描述.
研究的目的:
- 为了研究膀癌中USP1表达水平.
- 阐明USP1在膀癌进展中的功能作用.
- 为了确定膀癌的潜在治疗点.
主要方法:
- 使用GEPIA网络服务器进行USP1表达式分析.
- 构建USP1-淘汰和USP1-过度表达的膀癌细胞系 (UMUC3,T24).
- 细胞测试 (CCK8,殖民地形成,Transwell) 来评估增殖和迁移.
- RNA测序和双露西法酶记者测定用于识别信号通路.
- 同免疫沉和免疫光以研究USP1-c-MYC相互作用.
- 使用异种移植小鼠模型进行体内研究.
主要成果:
- 膀癌中USP1表达升高,与患者预后不佳相关.
- 过度表达USP1增强了膀癌细胞的增殖,克隆形成和迁移.
- 在体内,USP1缺乏会抑制瘤生长.
- 通过USP1.1,c-MYC途径被显著激活.
- USP1与c-MYC相互作用,并以催化依赖的方式增强其稳定性.
结论:
- 升高的USP1表达通过c-MYC稳定驱动膀癌的进展.
- USP1代表了膀癌治疗的潜在新型治疗点.
相关概念视频
Induced Pluripotent Stem Cells
3.9K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
3.9K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Anaphase Promoting Complex
2.8K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.8K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Regulated Protein Degradation
7.2K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.2K
The Proteasome
815
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
815


